Alx Oncology Holdings Inc. · NASDAQ:ALXO
GOODMAN COREY S reported a 10.00% stake in Alx Oncology Holdings Inc. (Schedule 13D/A)
Event Feb 2, 2026 · Filed Feb 4, 2026
GOODMAN COREY S reported a 10.00% stake in Alx Oncology Holdings Inc., 13,163,549 shares, with active intent on Feb 2, 2026. Filed Feb 4, 2026 (Schedule 13D/A).
- Stake
- 10.00%
- Shares
- 13,163,549
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| venBio Global Strategic Fund, L.P. | 3.40% | 4,431,600 |
| venBio Global Strategic Fund II L.P. | 6.40% | 8,453,038 |
| venBio Global Strategic GP, L.P. | 3.40% | 4,431,600 |
| venBio Global Strategic GP II, L.P. | 6.40% | 8,453,038 |
| venBio Global Strategic GP, Ltd. | 3.40% | 4,431,600 |
| venBio Global Strategic GP II, Ltd. | 6.40% | 8,453,038 |
| Adelman Robert J | 9.90% | 12,984,044 |
| GOODMAN COREY S | 10.00% | 13,163,549 |
Source
Related
- Alx Oncology Holdings Inc.
- Goodman Corey S
- Alx Oncology Holdings Inc. shareholders
- Schedule 13D/A · venBio Global Strategic Fund, L.P. · Oct 16, 2026
- Form 4 · Lettmann Jason · Aug 18, 2026
- Form 4 · Wong Shelly · Aug 18, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026